National Expenditure For False-Positive Mammograms And Breast Cancer Overdiagnoses Estimated At $4 Billion A Year
The DOI matches its Crossref record.
Abstract
Populationwide mammography screening has been associated with a substantial rise in false-positive mammography findings and breast cancer overdiagnosis. However, there is a lack of current data on the associated costs in the United States. We present costs due to false-positive mammograms and breast cancer overdiagnoses among women ages 40-59, based on expenditure data from a major US health care insurance plan for 702,154 women in the years 2011-13. The average expenditures for each false-positive mammogram, invasive breast cancer, and ductal carcinoma in situ in the twelve months following diagnosis were $852, $51,837 and $12,369, respectively. This translates to a national cost of $4 billion each year. The costs associated with false-positive mammograms and breast cancer overdiagnoses appear to be much higher than previously documented. Screening has the potential to save lives. However, the economic impact of false-positive mammography results and breast cancer overdiagnoses must be considered in the debate about the appropriate populations for screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Multiple hypothesis testing in experimental economics
List, J. A., Shaikh, A. M., & Xu, Y. (2019) · Experimental Economics · doi:10.1007/s10683-018-09597-5 · Cited by 463
A Deep Learning Model to Triage Screening Mammograms: A Simulation Study
Yala, A., Schuster, T., Miles, R., Barzilay, R., & Lehman, C. (2019) · Radiology · doi:10.1148/radiol.2019182908 · Cited by 210
“8 billion annually to health care costs in the United States alone (25).”
BackgroundA Review of Applications of Machine Learning in Mammography and Future Challenges
Batchu, S., Liu, F., Amireh, A., Waller, J., & Umair, M. (2021) · Oncology · doi:10.1159/000515698 · Cited by 41
Hughes, D. R., Espinoza, W., Fein, S., Rula, E. Y., & McGinty, G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4893 · Cited by 25
The economics of diagnostic safety
Slawomirski, L., Kelly, D., de Bienassis, K., Kallas, K.-A., & Klazinga, N. (2025) · OECD Health Working Papers · doi:10.1787/fc61057a-en · Cited by 20
Metadata
- Authors
- Ong, M.-S., & Mandl, K. D.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2015-04
- Volume
- 34
- Issue
- 4
- Pages
- 576-583
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2119270896
- Cited by
- 139
- References
- 0
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National Expenditure For False-Positive Mammograms And Breast Cancer Overdiagnoses Estimated At $4 Billion A Year. https://app.cochat.ai/papers/10.1377/hlthaff.2014.1087
- The paper
- Ong, M.-S., & Mandl, K. D. (2015). National Expenditure For False-Positive Mammograms And Breast Cancer Overdiagnoses Estimated At $4 Billion A Year. Health Affairs. https://doi.org/10.1377/hlthaff.2014.1087
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.